Deaths, causes of death, and incidence of t-AML
| . | All . | |
|---|---|---|
| n . | % of all deaths . | |
| Period in which death occurred | ||
| Induction | 117 | 78 |
| Consolidation | 13 | 8.7 |
| Maintenance | 11 | 7.3 |
| FU | 9 | 6.0 |
| Total | 150 | 100 |
| COD during induction | % of deaths during induction | |
| Bleeding | 69 | 59 |
| Infection | 33 | 28.2 |
| DS | 6 | 5.1 |
| Multiple causes | 5 | 4.3 |
| Congestive heart failure | 1 | 0.8 |
| Thrombosis | 1 | 0.8 |
| Missing | 2 | 1.7 |
| COD during consolidation | % of deaths during consolidation | |
| Infection | 12 | 92.3 |
| Congestive heart failure | 1 | 7.7 |
| COD during maintenance | % of deaths during maintenance | |
| Infection | 7 | 63.6 |
| Thrombosis | 1 | 9.1 |
| Secondary AML | 1 | 9.1 |
| Hemorrhage | 1 | 9.1 |
| Missing | 1 | 9.1 |
| COD off therapy | % of deaths after completion of the treatment | |
| Secondary AML | 3 | 33.3 |
| Car accident | 1 | 11.1 |
| Catastrophic antiphospholipid syndrome | 1 | 11.1 |
| Missing | 4 | 44.4 |
| Incidence of t-AML | % of cases after completion of consolidation | |
| t-AML | 4 | 0.65 |
| . | All . | |
|---|---|---|
| n . | % of all deaths . | |
| Period in which death occurred | ||
| Induction | 117 | 78 |
| Consolidation | 13 | 8.7 |
| Maintenance | 11 | 7.3 |
| FU | 9 | 6.0 |
| Total | 150 | 100 |
| COD during induction | % of deaths during induction | |
| Bleeding | 69 | 59 |
| Infection | 33 | 28.2 |
| DS | 6 | 5.1 |
| Multiple causes | 5 | 4.3 |
| Congestive heart failure | 1 | 0.8 |
| Thrombosis | 1 | 0.8 |
| Missing | 2 | 1.7 |
| COD during consolidation | % of deaths during consolidation | |
| Infection | 12 | 92.3 |
| Congestive heart failure | 1 | 7.7 |
| COD during maintenance | % of deaths during maintenance | |
| Infection | 7 | 63.6 |
| Thrombosis | 1 | 9.1 |
| Secondary AML | 1 | 9.1 |
| Hemorrhage | 1 | 9.1 |
| Missing | 1 | 9.1 |
| COD off therapy | % of deaths after completion of the treatment | |
| Secondary AML | 3 | 33.3 |
| Car accident | 1 | 11.1 |
| Catastrophic antiphospholipid syndrome | 1 | 11.1 |
| Missing | 4 | 44.4 |
| Incidence of t-AML | % of cases after completion of consolidation | |
| t-AML | 4 | 0.65 |
COD, cause of death; FU, follow-up.